Press Release Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option AgreementOption entitles Glaukos to exclusive global ...

this is a good opportunity for the market to finally realize what we have in Bausch + Lomb. I would keep a close eye on the potential buyout rumors because that is the most obvious means to see an ...

The debt refinancing is expected to help the company in the impending spinoff of its eye-care company, Bausch + Lomb. This drugmaker is expected to post quarterly earnings of $1.05 per share in ...

These muscles are responsible for shrinking and expanding the size of the pupil and iris in order to control the amount of light going into the eye. These muscles also protect the sensitive receptors ...

Bausch & Lomb (NYSE:BLCO) rose 9% after a report about private equity interest in a takeover of the eyecare company. Private equity firms including Blackstone (BX), Advent International, TPG ...

Blackstone, Advent International and TPG are among a long list of private equity firms studying bids for Bausch + Lomb ... in the more profitable eye care business. A sale, however, could satisfy ...

(Bloomberg) -- Bausch Health Cos. is working with Jefferies Financial Group to explore refinancing some of its debt to aid a long-planned spinoff of its stake in the eye-care company Bausch + Lomb, ...

Laval, Canada-based Bausch Health announced plans in 2020 to separate Bausch + Lomb into an independent, publicly traded company. The intent was to separate the eye care business, which includes ...

The report over the weekend said the eye-health company is in talks with Goldman Sachs to explore a deal and to seek interest from private equity firms. Bausch + Lomb split from its parent Bausch ...

(Bloomberg) -- Bausch + Lomb Corp. shares rose the most ever following a report that the eye-care company is considering selling itself to disentangle from its debt-laden parent company.

Bausch + Lomb) drops can be helpful. Although these are drops, they are preservative-free, non-irritating and can help protect the tear film from evaporation. I am optimistic that the movement toward ...

Current glaucoma treatments focus on the use of topical eye drops, surgery, or laser therapy, however the outcomes are variable, with some patients not responding and/or suffering serious side effects ...